These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

72 related items for PubMed ID: 9850451

  • 1. Serum total homocysteine concentration does not predict outcome in renal transplant recipients.
    Dimény E, Hultberg B, Wahlberg J, Fellström B, Arnadottir M.
    Clin Transplant; 1998 Dec; 12(6):563-8. PubMed ID: 9850451
    [Abstract] [Full Text] [Related]

  • 2. Fasting plasma total homocysteine levels and mortality and allograft loss in kidney transplant recipients: a prospective study.
    Winkelmayer WC, Kramar R, Curhan GC, Chandraker A, Endler G, Födinger M, Hörl WH, Sunder-Plassmann G.
    J Am Soc Nephrol; 2005 Jan; 16(1):255-60. PubMed ID: 15563562
    [Abstract] [Full Text] [Related]

  • 3. Impact of homocysteinemia on long-term renal transplant survival.
    Fonseca I, Martins L, Queirós J, Mendonça D, Dias L, Sarmento AM, Henriques AC, Cabrita A.
    Transplant Proc; 2005 Jan; 37(6):2784-8. PubMed ID: 16182810
    [Abstract] [Full Text] [Related]

  • 4. [Characteristics of hyperhomocysteinemia in dialysis patients].
    Lovcić V, Kes P, Reiner Z.
    Acta Med Croatica; 2006 Jan; 60(1):21-6. PubMed ID: 16802568
    [Abstract] [Full Text] [Related]

  • 5. Serum total homocysteine concentration before and after renal transplantation.
    Arnadottir M, Hultberg B, Wahlberg J, Fellström B, Dimény E.
    Kidney Int; 1998 Oct; 54(4):1380-4. PubMed ID: 9767559
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The treatment of hyperhomocysteinemia in patients on dialysis: folic acid or the high-flow polysulphonic membrane?].
    Lovcić V, Kes P, Zeljko R, Kusec V.
    Acta Med Croatica; 2006 Jun; 60(3):201-8. PubMed ID: 16933832
    [Abstract] [Full Text] [Related]

  • 8. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus.
    Bumbea V, Kamar N, Ribes D, Esposito L, Modesto A, Guitard J, Nasou G, Durand D, Rostaing L.
    Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508
    [Abstract] [Full Text] [Related]

  • 9. Rationale and design of the Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT) trial.
    Bostom AG, Carpenter MA, Kusek JW, Hunsicker LG, Pfeffer MA, Levey AS, Jacques PF, McKenney J, FAVORIT Investigators.
    Am Heart J; 2006 Sep; 152(3):448.e1-7. PubMed ID: 16923411
    [Abstract] [Full Text] [Related]

  • 10. [Renal graft survival in patients with systemic lupus erythematosus].
    Chew-Wong A, Soltero L, Diná E, Alvarez-Sandoval E, Alberú J, Gamba G, Correa-Rotter R.
    Rev Invest Clin; 2002 Sep; 54(1):21-8. PubMed ID: 11995403
    [Abstract] [Full Text] [Related]

  • 11. Reduced graft function (with or without dialysis) vs immediate graft function--a comparison of long-term renal allograft survival.
    Johnston O, O'kelly P, Spencer S, Donohoe J, Walshe JJ, Little DM, Hickey D, Conlon PJ.
    Nephrol Dial Transplant; 2006 Aug; 21(8):2270-4. PubMed ID: 16720598
    [Abstract] [Full Text] [Related]

  • 12. Histological factors of 1-h biopsy influencing the delayed renal function and outcome in cadaveric renal allografts.
    Oda A, Morozumi K, Uchida K.
    Clin Transplant; 1999 Aug; 13 Suppl 1():6-12. PubMed ID: 10751050
    [Abstract] [Full Text] [Related]

  • 13. Hyperhomocysteinemia in liver transplant recipients: prevalence and multivariate analysis of predisposing factors.
    Herrero JI, Quiroga J, Sangro B, Beloqui O, Pardo F, Cienfuegos JA, Prieto J.
    Liver Transpl; 2000 Sep; 6(5):614-8. PubMed ID: 10980061
    [Abstract] [Full Text] [Related]

  • 14. A multi-factor analysis of kidney regraft outcomes.
    Gjertson DW.
    Clin Transpl; 2002 Sep; ():335-49. PubMed ID: 12971460
    [Abstract] [Full Text] [Related]

  • 15. Metabolic factors and outcome of organ transplantation.
    Dimény E.
    Scand J Urol Nephrol Suppl; 1994 Sep; 159():1-74. PubMed ID: 7817159
    [Abstract] [Full Text] [Related]

  • 16. Determinants of fasting total serum homocysteine levels in liver transplant recipients.
    Akoglu B, Wondra K, Caspary WF, Faust D.
    Exp Clin Transplant; 2006 Jun; 4(1):462-6. PubMed ID: 16827644
    [Abstract] [Full Text] [Related]

  • 17. Outcome after kidney transplantation in children with thrombotic risk factors.
    Kranz B, Vester U, Nadalin S, Paul A, Broelsch CE, Hoyer PF.
    Pediatr Transplant; 2006 Nov; 10(7):788-93. PubMed ID: 17032424
    [Abstract] [Full Text] [Related]

  • 18. A long-term study on hyperlipidemia in stable renal transplant recipients.
    Tse KC, Lam MF, Yip PS, Li FK, Lai KN, Chan TM.
    Clin Transplant; 2004 Jun; 18(3):274-80. PubMed ID: 15142048
    [Abstract] [Full Text] [Related]

  • 19. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizień A, Głyda M, Gołembiewska E, Jankowska M, Nowosiad M, Rutkowski B, Ciechanowski K.
    Ann Acad Med Stetin; 2008 Jun; 54(1):41-8. PubMed ID: 19127808
    [Abstract] [Full Text] [Related]

  • 20. Plasma homocysteine levels in living kidney donors before and after uninephrectomy.
    Tsai MY, Aras O, Sozen H, Hanson NQ, Woll PS, Arends VL, Hunninghake DB, Matas AJ.
    J Lab Clin Med; 2004 Jun; 143(6):340-3. PubMed ID: 15192649
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.